Stryker welcomes the European Commission's targeted revision of the MDR. The proposal represents an important step toward creating a more efficient and predictable regulatory framework while maintaining the high standards of patient safety that remain central to the European medical technology ecosystem.
STR
Stryker
Company · Netherlands · EU Transparency Register 515621495542-36
3
positions filed
in the 665 files tracked
2
legislative files
of 665 tracked
2
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1210 companies & groups on this site, they rank #574 by legislative files engaged, a count of participation, not a measure of influence.
0.8
declared lobbying FTE
self-declared
€50K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2024
in the register since
Declares membership of
- MedTech Europe: MedTech Europe’s purpose is to make innovative medical technology available to more people, while hel…
- https://www.medtecheurope.org/
- AmCham EU: AmCham EU speaks for American companies committed to Europe on trade, investment and competitiveness issue…
- https://www.amchameu.eu/about
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
- Register category
- Companies & groups
- Head office
- Amsterdam, Netherlands
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Stryker in PolicySpeak: request access →
Work at Stryker? so we know who speaks for it.
Their record over time
Stryker filed 3 positions between 6 Oct 2025 and 3 Aug 2026, across 2 of the 665 legislative files tracked here, attaching a full position paper 2 times.
2025 · 2 filed2026 · 1 filed
What they argued
Thank you for the opportunity to provide feedback during this portion of the targeted revision initiative. The list below summarizes the changes that, in our opinion, present the best opportunities for strengthening, streamlining, and future-proofing the EU MDR.
We know that cigarette smoke is harmful, and measures exist to reduce its impact on public health. Yet surgical smoke (produced during 85% of surgical procedures(1)) is just as dangerous, and healthcare workers remain largely unprotected. Surgical smoke contains biological compounds that are irritating and carcinogenic.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Stryker next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Is this your organization?
Everything on this page comes from Stryker’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.